A study led by Drs. Alessandro Santin + Stefania Bellone found sacituzumab govitecan demonstrated encouraging efficacy in patients with recurrent #endometrialcancer, including those with aggressive tumor subtypes. medicine.yale.edu/cancer/publi... @oncoalert.bsky.social @aacrjournals.bsky.social

Sacituzumab Govitecan for Recurrent Endometrial Cancer

This study investigates sacituzumab govitecan, a Trop-2–targeted drug, showing 28% response in recurrent endometrial cancer and manageable safety in heavily

medicine.yale.edu

Drs. Amer Zeidan and Eric Winer welcome Tom, a patient cared for at Smilow Cancer Hospital, to discuss myelodysplastic syndrome #MDS and acute myeloid leukemia #AML, from both a physician and patient perspective. 🎧Listen live #WNPR 🔁Download on #ApplePodcasts or #Spotify 💻Listen later #YouTube

Join co-chair, Dr. Ehud Mendel, for the Inaugural New England Spine Tumor Course featuring multidisciplinary teams from leading spine oncology centers for focused training and interactive case-based discussions. 🗓️Aug. 21-22 📍New Haven, CT ➡️RSVP: bit.ly/4x8nZ32

Congratulations Dr. Alexandra Boye-Doe, Yale’s 1st graduate from the Hematology-Focused Fellowship Training Program (HFFTP) at @ash.hematology.org ! Dr. Boye-Doe has since received a #T32 and joined our Physician-Scientist training program to earn her PhD! @yale-hematology.bsky.social

Alongside #BIOCT, we are excited + proud to co-host the Future of Oncology Summit, Nov. 9-10, 2026, featuring leading voices in #oncology, high-impact networking, and strategic collaboration shaping the next era of #cancer innovation. ➡️https://futureofoncology2026.org

A new study published in @nature.com by @s-j-aitken.bsky.social shows how an individual's inherited genetic background shapes cancer risk, how tumors evolve, and how aggressively they progress + could lead to more personalized cancer prevention and treatment. medicine.yale.edu/cancer/publi...

Genetic Background Shapes Cancer Evolution and Tumor Progression

This study investigates how genetic background affects cancer evolution, showing that inherited genetic differences shape tumor growth, driver mutations, and

medicine.yale.edu

Dr. Ian Krop, director of the @yalecancer.bsky.social Clinical Trials Office, joins #YaleCancerAnswers tonight to discuss #clinicaltrials, the differences between phases 1-3, and why clinical trials are so important. 🎧Listen live #wnpr 🔁Download #ApplePodcasts 💻Listen later #YouTube

COMPASS, a new #AI model may help predict which patients with #cancer are most likely to respond to #immunotherapy. Dr. Harriet Kluger: “This is a very interesting study...Overall, it is an excellent first step.” resources.healthgrades.com/pro/ai-predi... @healthgrades.bsky.social

AI Model May Help Predict Which Cancer Patients Respond to Immunotherapy

A new AI model accurately predicted immunotherapy response across several cancer types, raising the possibility of more personalized cancer treatment in the future.

resources.healthgrades.com

Congratulations to Dr. Sanjay Aneja, awarded an #R37 MERIT Award from the #NCI to advance the development of artificial intelligence-derived imaging biomarkers for #prostatecancer. ➡️ bit.ly/4yG2SXy

Dr. Allison Shields presents "Modern Assessment of Image Quality in Fluoroscopy: Test Tools and Phantoms" this morning at #AAPMCOMP26. aapm.confex.com/aapm/2026am/...

A review by Dr. Julius Chapiro et al. shows how #AI is helping advance precision medicine in #livercancer care, analyzing medical images, pathology slides, + genomic data to improve diagnosis, predict outcomes, + support personalized care. medicine.yale.edu/cancer/publi... @jhepatology.bsky.social

AI Revolutionizes Precision Medicine in Liver Cancer Care

This study investigates how artificial intelligence improves precision medicine in liver cancer by enhancing diagnosis, prognostication, and treatment selection

medicine.yale.edu

Dr. Matthew Hoerner presented "Learning from the Data to Optimize Radiography Techniques" yesterday at #AAPMCOMP26. aapm.confex.com/aapm/2026am/...

Dr. Emily Draeger will be moderating a professional session this afternoon on "Burnout, Boundaries, and Balance - How to Set Boundaries and Lead a Balanced Life While Achieving Your Career Goals." #AAPMCOMP26 aapm.confex.com/aapm/2026am/...

Congratulations to Dr. Mehra Golshan on his election to the Academy of Master Surgeon Educators of the American College of Surgeons! medicine.yale.edu/cancer/news-...

New research from Dr. Sarah Goldberg shows combining Osimertinib + Gefitinib led to short-term benefits for some patients with EGFR-mutated advanced #NSCLC after resistance to osimertinib developed, underscoring the need for new treatment strategies. medicine.yale.edu/cancer/publi...

Osimertinib-Gefitinib Combo Shows Modest Benefits in EGFR NSCLC

This study investigates combining osimertinib and gefitinib in advanced lung cancer with EGFR C797S mutation, showing modest benefits but highlighting tumor

medicine.yale.edu

Congratulations to Drs. Katyayani Papatla; Sanjay Aneja; and Xiaomei Ma; recipients of 2026 Women’s Health and Cancer Research Pilot Project Awards! medicine.yale.edu/cancer/news-... @yalesph.bsky.social

Yesterday afternoon at #AAPMCOMP26, Anvi Sud presented "A Patient-Specific Digital Twin for Adaptive Radiotherapy of Non-Small Cell Lung Cancer." aapm.confex.com/aapm/2026am/...

Yesterday, we had five poster presentations at #AAPMCOMP26 featuring Dr. Yiu-Hsin Chang; Dr. Huixiao Chen; Yuchen Jessie Jiang; Dr. Sameer Taneja; and Xinran Li! aapm.confex.com/aapm/2026am/...

Dr. Allison Shields moderated a session yesterday at #AAPMCOMP26 on Spectral CT imaging. aapm.confex.com/aapm/2026am/...

Tonight on Yale Cancer Answers, @muzumdarlab.bsky.social discusses the dramatic rise in #pancreaticcancer and how his lab is studying whether the types of fats we consume may contribute to the development of #cancer. 🎧Listen live #wnpr 🔁Download #ApplePodcasts 💻Listen later #YouTube

Dr. Huixiao Chen is presenting this morning at #AAPMCOMP26 in Room 109 on "Clinical Physics Experience with CRAD SGRT for Multi-Tumor-Site Patient Setup and  Intrafraction Motion Monitoring." aapm.confex.com/aapm/2026am/...

Congratulations to Drs. Yiu-Hsin Chang; Dae Yup Han; and Sameer Taneja for their research being selected for digital poster viewing at #AAPMCOMP26. aapm.confex.com/aapm/2026am/...

We're proud that faculty and researchers from our #RadiationOncology team will be participating and contributing their expertise at AAPM | COMP Annual Meeting & Exhibition this weekend! #AAPNCOMP26 aapm.confex.com/aapm/2026am/...

Please repost! We are seeking #PostDocs to join our lab @yale.edu @yalecancer.bsky.social to study #genetic and #host drivers of #PancreaticCancer and #LungCancer. Check out our newly updated website for more lab details! medicine.yale.edu/lab/muzumdar/

Dr. Cary Gross @carygross.bsky.social discusses financial conflicts of interest across #cancercare and research, along with his recent #JNCI study highlighting the prevalence of industry ties throughout the US cancer ecosystem. medicine.yale.edu/cancer/news-...

Understanding Financial Conflicts of Interest in Cancer Care and Research

Yale School of Medicine's Cary Gross, MD, has been investigating financial conflicts of interest in American medicine for more than 20 years. In a Q&A, he

medicine.yale.edu

Dr. Francine Foss @yale-hematology.bsky.social, director of the @yalecancer.bsky.social T-cell Lymphoma Program + co-chair of #TCLF, discusses recent advances in peripheral T-cell lymphoma therapy, including novel treatment pathways + targetable mutations. #PETAL youtu.be/OxylKmt8vzI?...

Advances in Peripheral T-cell Lymphoma Treatment | Francine Foss, MD

YouTube video by HOPE-PTCL

youtu.be

Dr. Ira Leeds received a @deptvetaffairs.bsky.social Career Development Award to study to how psychosocial risk factors contribute to complications following major #cancer surgery among #Veterans. medicine.yale.edu/cancer/news-...

Congratulations to Amos Espinosa, PhD candidate in the #KrauseLab, recipient of the Ruth L. Kirschstein NRSA for Individual Predoctoral Fellows #F31 Award from the #NCI! This award will support his research into megakaryoblastic #leukemia. medicine.yale.edu/cancer/news-... @yalepathology.bsky.social

New research from Dr. Michaela Dinan @yalesph.bsky.social suggests benefits of 3D breast imaging #DBT may differ by age. In women 67–74, it was associated with detection of smaller, lower-grade tumors. At 75+, benefits were limited. medicine.yale.edu/cancer/publi...

Tomosynthesis vs Conventional Mammography: Breast Cancer Detection in the Elderly

This study investigates the benefits of digital breast tomosynthesis over conventional mammography in older women, showing limited advantage in detecting

medicine.yale.edu

A study by Drs. Jay Bader + Kiran Turaga shows importance of genetic testing in pleural #mesothelioma to improve prognostication + enrollment in #clinicaltrials for targeted therapies. Genetic mutations had less prognostic impact in peritoneal mesothelioma. medicine.yale.edu/cancer/publi...

Prognostic Role of NF2 and TERT Mutations in Mesothelioma

This study investigates the prognostic impact of somatic mutations in mesothelioma, showing NF2 truncating variants worsen survival, supporting genomic testing

medicine.yale.edu